Globus Medical Inc
NYSE:GMED
Wall Street
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for
GMED
is 62.69 USD
with a low forecast of 25.25 USD and a high forecast of 87.15 USD.
GMED Last Price Targets
Globus Medical Inc
The latest public price target was made on Mar 18, 2024 by
Ryan Zimmerman
from
BTIG
,
who expects
GMED
stock to
rise by 19%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ryan Zimmerman
BTIG
|
60
USD
Upside 19% |
1 month ago
Mar 18, 2024
|
BTIG Upgrades Globus Medical (GMED) to Buy
StreetInsider
|
Mathew Blackman
Stifel Nicolaus
|
61
USD
Upside 21% |
7 months ago
Sep 19, 2023
|
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMED's stock price target?
Price Target
62.69
USD
According to Wall Street analysts, the average 1-year price target for
GMED
is 62.69 USD
with a low forecast of 25.25 USD and a high forecast of 87.15 USD.
What is Globus Medical Inc's Revenue forecast?
Projected CAGR
23%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
23%.
What is Globus Medical Inc's Operating Income forecast?
Projected CAGR
49%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's operating income is
3%.
The projected
CAGR
for the next 3 years is
49%.
What is Globus Medical Inc's Net Income forecast?
Projected CAGR
64%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's net income is
1%.
The projected
CAGR
for the next 3 years is
64%.
You don't have any saved screeners yet
